An incredibly harmful law included in President Biden’s misleadingly named Inflation Reduction Act is the ability for Washington to impose price controls on a growing range of medications used by Medicare recipients.
This section of What’s Ahead clarifies how the arbitrary enforcement of lower prices on pharmaceutical companies will obstruct essential research and development of new, life-saving drugs, as well as the improvement of existing ones.
The United States spends significantly more on research compared to any other nation in the world. However, these expenditures are beginning to decline, and the repercussions will be fatal.
